Reversible hyporegenerative anemia during natalizumab treatment.

Sorry, there's nothing here.

Topics

Cite this paper

@article{Monteleone2015ReversibleHA, title={Reversible hyporegenerative anemia during natalizumab treatment.}, author={Fabrizia Monteleone and Francesco Buccisano and Luisa Boffa and Fabio Buttari and Ambra Di Veroli and Gaetano Borriello and S. Rossi and Diego Centonze}, journal={Multiple sclerosis}, year={2015}, volume={21 2}, pages={257-8} }